The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - AstraZeneca

BEGONIA: Phase 1b/2 study of durvalumab (D) combinations in locally advanced/metastatic triple-negative breast cancer (TNBC)—Initial results from arm 1, d+paclitaxel (P), and arm 6, d+trastuzumab deruxtecan (T-DXd).
 
Peter Schmid
Employment - Roche (I)
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Genentech/Roche; Merck; Novartis; Pfizer; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Novartis (Inst); OncoGenex (Inst); Roche (Inst)
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; GlaxoSmithKline; Hanmi; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Daewoong Pharmaceutical (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
 
Anne Armstrong
Stock and Other Ownership Interests - AstraZeneca (I)
Honoraria - Lilly; MSD
Research Funding - AstraZeneca
 
Yeon Hee Park
Honoraria - Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Eisai; Pfizer; Roche
Research Funding - AstraZeneca; Merck; Novartis; Pfizer
Travel, Accommodations, Expenses - Merck; Novartis
 
Wei-Pang Chung
Honoraria - Amgen; AstraZeneca; Chugai Pharma; Foundation Medicine; Kyowa Kirin; Lilly; Novartis; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Lilly; Novartis; Pfizer
 
Zbigniew Nowecki
Travel, Accommodations, Expenses - Roche
 
Simon Lord
Stock and Other Ownership Interests - Mitox Therapeutics
Honoraria - Eisai; Prosigna
Consulting or Advisory Role - Shionogi
Research Funding - Pathios Therapeutics
Travel, Accommodations, Expenses - Roche
 
Piotr Jan Wysocki
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
Yen-Shen Lu
Honoraria - AstraZeneca; Daiichi Sankyo/UCB Japan; Eisai; Eurofarma; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Research Funding - Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Eisai; Novartis; Pfizer; Roche
 
Hannah Dry
Employment - AstraZeneca
 
Vatsala Karwe
Employment - AstraZeneca
 
Ross Stewart
Employment - AstraZeneca; AstraZeneca/MedImmune; Pfizer
 
Pia Herbolsheimer
No Relationships to Disclose
 
Ana Tablante Nunes
Employment - AstraZeneca
 
Kyung Hae Jung
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Novartis; Roche; Takeda